Insufficient scRNA-seq data for expression of FZD8 at single-cell level.
Insufficient scRNA-seq data for expression of FZD8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1118.44 | 89 / 89 | 95% | 16.65 | 856 / 901 |
thymus | 100% | 1418.20 | 653 / 653 | 95% | 14.88 | 574 / 605 |
breast | 100% | 776.16 | 459 / 459 | 93% | 19.18 | 1041 / 1118 |
stomach | 100% | 1062.04 | 359 / 359 | 89% | 12.13 | 255 / 286 |
pancreas | 100% | 505.02 | 327 / 328 | 89% | 10.28 | 158 / 178 |
intestine | 97% | 1180.89 | 941 / 966 | 89% | 8.79 | 467 / 527 |
lung | 97% | 808.46 | 560 / 578 | 86% | 11.71 | 992 / 1155 |
prostate | 73% | 229.16 | 180 / 245 | 97% | 15.80 | 486 / 502 |
uterus | 95% | 476.29 | 162 / 170 | 71% | 16.02 | 324 / 459 |
esophagus | 76% | 484.50 | 1093 / 1445 | 76% | 8.33 | 139 / 183 |
ovary | 76% | 323.28 | 136 / 180 | 76% | 13.08 | 325 / 430 |
bladder | 81% | 338.29 | 17 / 21 | 52% | 5.36 | 263 / 504 |
brain | 69% | 365.00 | 1836 / 2642 | 62% | 5.94 | 440 / 705 |
liver | 94% | 306.58 | 212 / 226 | 36% | 3.29 | 146 / 406 |
skin | 97% | 642.52 | 1750 / 1809 | 31% | 6.46 | 147 / 472 |
adrenal gland | 83% | 245.92 | 215 / 258 | 41% | 3.35 | 94 / 230 |
spleen | 100% | 2240.96 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1387.73 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 879.98 | 1198 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 978.56 | 850 / 861 | 0% | 0 | 0 / 0 |
muscle | 92% | 333.29 | 740 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 9.41 | 35 / 45 |
eye | 0% | 0 | 0 / 0 | 65% | 4.35 | 52 / 80 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.36 | 3 / 29 |
peripheral blood | 0% | 0.76 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0030182 | Biological process | neuron differentiation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0098992 | Cellular component | neuronal dense core vesicle |
GO_1990851 | Cellular component | Wnt-Frizzled-LRP5/6 complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD8 |
Protein name | Frizzled-8 (Fz-8) (hFz8) |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins. Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalosomes. The beta-catenin canonical signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Coreceptor along with RYK of Wnt proteins, such as WNT1. . |
Accessions | Q9H461 ENST00000374694.3 |